To date, only three studies have evaluated the effects of TAAR1 agonists on nicotine-related behaviors and demonstrated the inhibitory effects of the TAAR1 agonists on nicotine addiction, relapse to nicotine, and nicotine withdrawal [110,111,112]. The gene discussed is TAAR1; the disease is nicotine dependence.